Originally published In Press as doi:10.1074/jbc.M000676200 on April 20, 2000
J. Biol. Chem., Vol. 275, Issue 25, 19324-19333, June 23, 2000
Isoforms of Kalirin, a Neuronal Dbl Family Member, Generated
through Use of Different 5'- and 3'-Ends Along with an Internal
Translational Initiation Site*
Richard C.
Johnson,
Peter
Penzes,
Betty A.
Eipper, and
Richard E.
Mains
From the Department of Neuroscience, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205
Received for publication, January 29, 2000, and in revised form, March 29, 2000
 |
ABSTRACT |
Kalirin is a neuron-specific GDP/GTP exchange
factor for Rho subfamily GTP-binding proteins. The major Kalirin
transcripts in adult rat brain were identified. Most include a
Sec14p-like putative lipid-binding motif followed by nine spectrin-like
repeats and a Dbl homology/pleckstrin homology (DH-PH) domain. Kalirin proteins with four different NH2 termini are
generated through the use of five different 5'-ends; three of the
proteins differ only at the extreme NH2 terminus, and one
is truncated because translation is initiated at a methionine in the
5th spectrin repeat. Four different 3'-ends yield Kalirin proteins with
additional functional domains. Kalirin-7 (7-kilobase pair mRNA)
terminates with a PDZ-binding motif, which in Kalirin-8 is replaced by
an SH3 domain. Kalirin-9 contains another pair of DH-PH and SH3
domains. Kalirin-12 additionally encodes a putative Ser/Thr protein
kinase. Antisera specific for different COOH termini established
Kalirin-7 as the most abundant in cortex, with significant amounts of
Kalirin-9 and Kalirin-12; Kalirin-7 was less prevalent in cerebellum
and olfactory bulb. Kalirin proteins lacking the Sec14p-like domain and
first four spectrin-like repeats were much less prevalent. Form-specific antisera demonstrated that different forms of Kalirin were localized to distinct subcellular regions of cultured neurons. Members of the family of Kalirin proteins may subserve different functions at these different locations.
 |
INTRODUCTION |
The Dbl family of GDP/GTP exchange factors
(GEFs)1 for small GTP-binding
proteins of the Rho subfamily is large and growing (1-4) (Fig.
1). Adjacent DH and PH domains are common
to all family members, with various additional domains present in the NH2- and COOH-terminal ends. Dbl and many of the earliest
members of this protein family were identified through their oncogenic activity; several were found to be especially prevalent in the nervous
system (2). More recently, neuron-specific members of the Dbl family
such as Kalirin (see below) and collybistin (5) have been identified
through protein-protein interaction screens.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
Relationship of known Kalirin isoforms to
homologous proteins from C. elegans and man.
Kalirin-7 and Kalirin-8 transcripts encoding three different
NH2 termini have been identified; * denotes the unique 4-, 22-, or 24-amino acid sequences preceding the divergence point.
Dbl is the founding member of this family of GEFs (1, 2,
44). Trio was identified by its ability to bind to LAR, a
receptor type protein tyrosine phosphatase (13); in their overlapping
regions, the amino acid sequences of rat Kalirin and human Trio are
73% identical. C. elegans has a single Kalirin/Trio-like
gene, unc-73; UNC-73A is the longer of the two splice
variants observed (14). Duet, identified in human skeletal muscle,
encodes a protein 95% identical to rat Kalirin-8 in their region of
overlap (19); the remainder of the Duet transcript encodes a protein
47% identical to the corresponding region of Trio. Sec14p-, spectrin-,
SH3, PDZ-binding, Ig-, FnIII- and protein kinase-like domains are
indicated, along with demonstrated DH-PH domains.
|
|
Kalirin was identified as a protein interacting with the COOH-terminal
cytoplasmic tail of the peptide-processing enzyme peptidylglycine
-amidating monooxygenase (PAM) (6). Kalirin (Duo) was also identified as an interactor with Huntingtin-associated protein-1 (7)
and the inducible form of nitric-oxide synthase (8). Kalirin is found
in a large fraction of central nervous system neurons, notably in long
projection neurons (9). When expressed in pituitary tumor cells,
Kalirin increases the length and branching patterns of processes and
facilitates regulated secretion (9, 10). By forming heterodimers with
iNOS and inactivating it, Kalirin restores stimulated secretion to
cells in which secretion has been inhibited by induction of iNOS (8).
The role of Kalirin in the normal functioning of the nervous system has
not yet been explored.
The first forms of rat Kalirin identified (called P-CIP10a and -10b)
differed only at their 5'-ends, sharing a phospholipid binding motif
(11), nine spectrin-like repeats, a single DH-PH domain, and an SH3
domain (9). The sequences of human Kalirin (Duo), P-CIP10a and -10b,
diverged at the same point near the NH2 terminus (7). Human
Kalirin (Duo) lacked an SH3 domain, terminating instead with a putative
PDZ recognition motif (7, 12). A homologous rat transcript was recently
identified; based on the size of this transcript, it is referred to as
Kalirin-7 (12). Similarly, P-CIP10a and -10b will be referred to as
Kalirin-8a and -8b, respectively, since both correspond approximately
to 8-kb mRNAs.
Current data suggested that additional forms of Kalirin remain to be
identified. On Northern blots, Kalirin-7 is a major transcript, with
other Kalirin mRNAs ranging in size from 5 to 15 kb. When used to
analyze extracts of rat cortex, antibodies to the spectrin-like region
of Kalirin recognized proteins ranging in size from 115 to 420 kDa
(12). Kalirin-7, a major protein of 190 kDa, was uniquely localized to
the postsynaptic density fraction. Trio and UNC-73A, the closest
homologues to Kalirin, are extended COOH-terminally to contain domains
not present in Kalirin-7 or -8 (13, 14) (Fig. 1).
Here we report the cloning of three new forms of Kalirin, designated
Kalirin-
7, Kalirin-9, and Kalirin-12. The basic approach was to
employ 5'- and 3'-RACE to extend known sequence and identify distinct
transcripts. Form-specific cDNA probes were used for Northern
analyses, and RT-PCR was used to confirm and determine 5'-splice
variants. Finally, form-specific antisera were employed to identify the
corresponding proteins in brain extracts and to localize the endogenous
proteins in cultured neurons.
 |
EXPERIMENTAL PROCEDURES |
Northern Analyses--
Total RNA from rat parietal cortex and
liver was prepared using RNA Stat-60 (Tel-Test Inc).
Poly(A)+ RNA was prepared using the Promega poly(A) Ttract
mRNA Isolation System. Equal amounts (1 µg) of
poly(A)+ RNA from liver and cortex were loaded side by side
in quadruplicate on a 0.9% agarose gel containing formaldehyde (15).
After electrophoresis and transfer to a Nytran+ membrane (Schleicher & Schuell), the membrane was cut into 4 equivalent strips, each
containing liver and cortex RNA samples. The strips were hybridized
with random primed cDNA probes using standard techniques (15),
except that Ultrahyb hybridization solution (Ambion) was used to
increase the signal for the Kalirin-8 COOH terminus probe. Each blot
was stripped by heating briefly to 100 °C in 1% SDS, 0.01× salt
sodium citrate before hybridizing to different probes. The probes
correspond to the following regions of Kalirin: spectrin domains 1-3
(nt 580-1531), spectrin domains 3-8 (nt 1364-3398), DH1-PH1 (nt
3790-4635), Kalirin-8 COOH terminus (nt 5518-5728) in Kalirin-8a;
Kalirin-7 3'-end (nt 4865-5087) in Kalirin-7a; DH2-PH2 (nt 5667-6689)
and Kal-9 3'UTR (nt 7151-7680) in Kalirin-9a; and Kalirin kinase (nt 7223-8950) in Kalirin-12a. Kalirin is not expressed in liver (9), which served as a negative control. Nucleotide numbering is based on
the 5'-end of P-CIP10a. The Kalirin-7 GenBankTM accession
number is AF230644.
RT-PCR for Alternate 5'-Ends--
Oligo(dT)-primed cDNA was
made from 1 µg of rat parietal cortex total RNA using Superscript II
Reverse Transcriptase (Life Technologies, Inc.) in a 20-µl reaction.
Negative control samples for PCR were processed as above without
Superscript II. The Expand High Fidelity PCR system (Roche Molecular
Biochemicals) was used for all PCRs, following the manufacturer's
protocol. cDNA template (2 µl) was amplified for 30 cycles in all
reactions. Approximately 1/5 of each reaction was electrophoresed on a
0.8% agarose gel and transferred to Nytran+ membrane (Schleicher & Schuell) for Southern analysis. Table I
shows the primers used for PCR.
Cloning of
Kalirin-7 (Kalirin-5)--
Screening of a
-ZAPII rat hippocampal random primed cDNA library has been
described previously (9). Two clones with a unique 5'-end upstream of
nt 1735 in Kalirin-7a (
10/29,
10/40) were rescued into
pBluescript II SK
(Stratagene). pBS.10/29 had a 2.8-kb insert with 64 bp of unique 5'-sequence, and pBS.10/40 had a 2.58-kb insert that
extended 30 bp further 5' than
10/29. To confirm this junction,
RT-PCR was performed as described above using sense primer
5'-GGGAATTCCGACTCTCTTGACTCTC-3' containing an
EcoRI site (underlined) and antisense primer
5'-GCTGCTGGAGGACAGACT-3' (nt 2209-2192). cDNA products of 569 and
858 bp (containing an additional 289 bp inserted in front of nt 1735)
were amplified by this reaction. Both products were sequenced using the
Sequenase PCR product sequencing kit (United States Biochemical Corp.). The
Kalirin-7 (Kalirin-5) GenBankTM accession number is
AF229255.
In Vitro Transcription/Translation--
pBS.Kal-5TnT was
constructed by digesting pBS.10/29 with BamHI, which cuts at
nt 2689 in Kalirin and in the 3' polylinker. After gel purification,
the 4.0-kb fragment containing the vector and the first 1.0 kb of
10/29 was re-ligated to create a construct with an open reading
frame of 798 bp, from nt 1894 to immediately after the BamHI
site at the 3' polylinker (see Fig. 3B). Since there was an
EcoRI site 7 bp from the 5'-end of the 289-bp insert in the
858-bp PCR product described above, this product was digested with
EcoRI and BglII (cuts at nt 1812 in Kalirin); the
359-bp fragment obtained was cloned into EcoRI (5'
polylinker)-BglII-cut pBS.Kal-5TnT to create pBS.Kal-5.3TnT.
The Promega TNT-coupled Reticulocyte system was used for in
vitro transcription/translation reactions. Briefly, radiolabeled
proteins were synthesized from 0.5 µg of plasmid DNA using 25 µCi
of [35S]methionine (Amersham Pharmacia Biotech) in a
25-µl reaction; aliquots (2 µl) were analyzed by 12% SDS-PAGE. The
gel was treated with Amplify (Amersham Pharmacia Biotech), dried, and
exposed to film for 18 h.
Cloning of Kalirin-9 and Kalirin-12--
A 3'-RACE protocol was
used to isolate the 3'-end of rat Kalirin-9 (16). cDNA was
synthesized from 1 µg of rat parietal cortex total RNA using
Superscript II (Life Technologies) and a RACE hybrid primer
5'-GGAATTCGAGCTCATCGAT17-3' in a 20-µl reaction. cDNA
(2 µl) was initially amplified for 30 cycles using a RACE Adapter
antisense primer, 5'-GGAATTCGAGCTCATCGA-3', and a sense primer,
5'-CTGCTTCTTCCCCCTGGTGA-3', located at nt 5097-5115 in Kalirin-8 thus
preventing any possibility of amplifying Kalirin-7 sequences. This
reaction (1 µl) was amplified for 30 cycles using the RACE Adapter
primer and a nested sense primer containing an XbaI site
(underlined), 5'-GGTCTAGAATGGAGGCAAGTCTGAGT-3' (nt
5143-5164). An ~2.5-kb fragment was subcloned into pBS II SK
, and
sequencing revealed that this clone diverged from Kalirin-8 at nt 5508, adding another 1.55 kb of open reading frame plus about 0.5 kb of
3'-UTR (see Fig. 4A, below). Another clone diverged at nt
5601 and was otherwise the same as the initial clone, indicating that a
93-bp fragment is sometimes spliced out. The Kalirin-9
GenBankTM accession number is AF232668.
The rat Kalirin-12 3' sequence was identified by amplifying rat
parietal cortex cDNA with a sense primer, 10/28-RACE 3', located at
nt 4592-4611 containing an XbaI site,
5'-CCTCTAGAGCACCCCATCCTCAGACAAT-3', and an antisense primer
based on the human Duet sequence (GenBankTM accession
number NM_007064 (RNA) or 5902140 (protein)) containing a
SalI site, 5'-GGGGTCGACACTGCACGTCTATGTGAA-3' (nt
4028-4008). An ~4.4-kb fragment was subcloned into pBS II SK
, and
sequencing revealed that this fragment diverged 15 bp from the end of
the coding region of Kalirin-9 and had an open reading frame that extended 1763 bp in the 3' direction (see Fig. 5A, below).
PCRs were performed using the Expand High Fidelity PCR system (Roche Molecular Biochemicals). Sequencing was done using the Sequenase 7-deaza-dGTP sequencing kit (United States Biochemical Corp.). Multiple
clones from independent sources of cDNA were sequenced to identify
and eliminate any errors generated during cDNA amplifications. The
Kalirin-12 GenBankTM accession number is AF232669.
Antisera--
Rabbit polyclonal antisera to Kalirin-spectrin and
Kalirin-7 were described previously (12). Rabbit polyclonal antisera were generated at Covance (Denver, PA) by immunizing rabbits with the
following antigens. Kalirin-SH3 (JH2960) was generated against the
glutathione S-transferase fusion of the SH3 domain of
Kalirin (amino acids 1617-1684 of Kalirin-8a); Kalirin-9 antiserum
(JH3090) was generated against the synthetic peptide comprising the
COOH-terminal 19 residues of rat Kalirin-9
(K2326ATAPAESSDESIKTLLKP2344;
residues unique to Kalirin-9 are bold); Kalirin-kinase antiserum (JH3226) was generated against a synthetic peptide comprising the
COOH-terminal 17 residues of rat Kalirin-12
(P2943IPNVKSYIVNRVNQGT2959). Both peptides were
synthesized by Dr. Henry Keutmann (Endocrine Unit, Massachusetts
General Hospital) and were cross-linked to keyhole limpet hemocyanin
with 0.1% glutaraldehyde (2 mg of peptide/5 mg) prior to injection.
Antibodies JH2958, JH2960, JH3090, and JH3226 were affinity-purified
using their respective antigenic peptides linked to Affi-Gel 10. Affinity-purified antibodies were used at a final dilution of 1:100. No
immunostaining was detected when the antibodies were pre-bound to their
corresponding antigenic peptides.
Tissue and Cell Culture Preparations--
Parietal cortex and
hippocampi were dissected from adult female Harlan Sprague-Dawley rats
(Harlan), and tissues were homogenized in 10 volumes of RIPA buffer (50 mM Tris HCl (pH 8.0), 120 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate, containing phenylmethylsulfonyl fluoride (0.3 mg/ml), and a protease inhibitor mixture (lima bean trypsin inhibitor (50 µg/ml), leupeptin (2 µg/ml), benzamidine (16 µg/ml), and pepstatin (2 µg/ml)) with 10 strokes of a glass/Teflon homogenizer. Insoluble materials were
removed by centrifugation at 15,000 × g for 10 min.
Primary cultures of cortical neurons from E17-E18 rat pups were
prepared by established methods and processed for immunocytochemistry
(12).
For immunoprecipitation, homogenate supernatants (2.5 mg of protein)
diluted 1:2 in wash buffer (20 mM Tris-HCl, pH8.0, 100 mM NaCl, 1% Triton X-100, and 0.3 mg/ml
phenylmethylsulfonyl fluoride) were incubated with Kalirin-spectrin
antibody (10 µl). After a 1 h incubation at 4 °C, 20 µl of
protein-A Sepharose (Sigma) was added, and samples were tumbled for
1 h at 4 °C. The resin was collected by centrifugation at
5000 × g for 1 min and washed 4 times with wash
buffer. The bound proteins were eluted by boiling the resin in 200 µl
of 1× SDS-PAGE loading buffer and analyzed by SDS-PAGE and Western blotting.
 |
RESULTS |
Northern Blot Analysis Reveals Kalirin Transcripts with Different
5'- and 3'-Ends--
Northern blot analysis of adult rat parietal
cortex RNA using probes specific to different regions of the two cloned
Kalirin transcripts (Kalirin-7 and Kalirin-8) revealed a complex
hybridization pattern with multiple RNA species ranging in mass from
about 5 kb to greater than 15 kb (Fig.
2). Probes encompassing Kalirin spectrin-like domains 3-8 or the DH-PH domains (lanes 2 and
3, respectively) yielded very similar patterns; major
transcripts of 7.3 and 5.3 kb were detected, whereas at least three
larger transcripts (9, 10, and 12 kb) were present at lower levels. A probe corresponding to the COOH terminus of Kalirin-8 (lane
4) hybridized to minor transcripts of 6.8, 9, 10, 12, and greater than 15 kb. A probe specific for the 3'-end of Kalirin-7 (lane 5) hybridized only to the major transcripts (7.3 and 5.3 kb). A
probe encompassing spectrin-like domains 1-3 (lane 1)
hybridized to the major 7.3-kb transcript as well as to minor
transcripts of 9, 10, 12, and greater than 15 kb. Even though the blot
shown in lane 1 has been overexposed, it is clear that a
5.3-kb transcript was not detected by this probe. A probe specific for
the extreme 5'-end of Kalirin also failed to detect a 5.3-kb transcript
(data not shown). The presence of a 5.3-kb mRNA (Kalirin-5) in
lanes 2, 3, and 5, but not in lane 1,
suggests that this transcript is a 5'-truncated version of Kalirin-7.
As expected (9), none of the probes detected cross-reactive transcripts
in liver mRNA (not shown).

View larger version (71K):
[in this window]
[in a new window]
|
Fig. 2.
Northern blot analysis with probes specific
for different regions of Kalirin-7 and Kalirin-8. Replicate
samples of poly(A)+ RNA (1 µg) from adult rat parietal
cortex were fractionated on a denaturing agarose gel and transferred to
a nylon membrane. Strips of membrane were hybridized with cDNA
probes encompassing the indicated regions of Kalirin (open
bars): numbering from Kalirin-8a, spectrin-like domains 1-3 (nt
580-1531), spectrin-like domains 3-8 (nt 1364-3398), DH1-PH1 (nt
3790-4635), and Kalirin-8 COOH terminus (nt 5518-5728; K-8 C-ter);
numbering from Kalirin-7a, Kalirin-7 3'-end (nt 4865-5087; K-7
3'-end).
|
|
Although Kalirin-8 was the first form of Kalirin identified (9), it is
not an abundant transcript in the adult. The COOH-terminal end of
Kalirin-7 lacks the final 283 amino acids of Kalirin-8, terminating
instead with a unique 20 amino acid sequence ending in a putative PDZ
recognition motif, -STYV (12). Based on hybridization to a probe
specific for the 3'-end of Kalirin-7 (Fig. 2, lane 5), the
two most abundant transcripts (7.3 and 5.3 kb) are the only Kalirin
transcripts that have this COOH terminus. Western blot analysis of
cortical extracts also demonstrated that the Kalirin-7 protein was
highly expressed relative to the other Kalirin forms (Ref. 12 and Fig.
8, B and C).
Characterization of 5.3-kb Kalirin Transcript--
In RNA from
adult parietal cortex, the 5.3-kb Kalirin transcript is the most
prevalent form (Fig. 2). RT-PCR using a sense primer positioned at the
Kalirin start ATG and an antisense primer positioned at the Kalirin-7
stop (Fig. 3A) amplified a
single 5-kb fragment (12). Taken together with the Northern blotting data from Fig. 2, we speculated that the 5.3-kb Kalirin transcript possessed a unique 5'-end and was not the result of alternative splicing within the Kalirin-7-coding region. Screening a random primed
rat hippocampal cDNA library with a probe to spectrin-like domains
3-8 of Kalirin yielded two clones whose sequences were identical to
Kalirin-7 downstream of nt 1735 but distinct from Kalirin-7 upstream of
this divergence point (Fig. 3B). Clone 10/29 had 64 bp of
new 5' sequence and clone 10/40 extended 30 bp further upstream.
Remarkably, this new sequence did not include an in-frame methionine
codon but did contain a stop codon in-frame with the downstream
Kalirin-coding sequence (Fig. 3B, *). Therefore, if the
corresponding mRNAs were translated, initiation from a downstream site would be required. The first in-frame methionine codon encountered (nt 1894-1896) occurs at the start of the fifth spectrin-like domain
of Kalirin-7 (Fig. 3, A and B).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 3.
Kalirin-5 has a unique 5'-end.
A, the 5'-coding region of Kalirin-7a is shown along with
relevant domains, the identified divergence point (nt 1735), and
primers used for RT-PCR (S, sense, and AS,
antisense, with arrows). B, Kalirin cDNA
inserts having a unique truncated 5'-end were isolated by screening a
hippocampal library as described under "Experimental Procedures";
clone 10/29 (2.8 kb) has 64 bp of unique sequence 5' to nt 1735 and
clone 10/40 (2.6 kb) extends 30 bp further. The in-frame stop codon is
indicated by an asterisk and the BamHI site by
B. C, the indicated sense (S) and
antisense (AS) primers were used for RT-PCR. Kalirin-5.3
contains an extra 289 bp (stippled region);
asterisks indicate in-frame stop codons upstream of the ATG
at 1894. The checkered region identifies nt 1735-1894, part
of the coding region in Kalirin-7a, but part of the 5'-UTR of Kalirin-5
and -5.3. The vertical striped region indicates 5'-UTR
unique to the truncated RNA forms. D, vectors used for
in vitro transcription/translation. pKal-5.3TnT lacks the
first 64 bp of pKal-5TnT and the first 7 bp of the retained intron
(stippled box in C). E, pKal-5TnT and
pKal-5.3TnT were translated in vitro using
[35S]methionine. Products were separated by SDS-PAGE and
analyzed by fluorography. The 32-kDa product produced by both plasmids
is consistent with initiation of translation at A1894TG in
Kalirin-7a. F, the domains of Kalirin-5 are drawn
to scale; predicted molecular mass, 117 kDa.
|
|
To confirm the presence of this alternative 5'-end, RT-PCR was
performed on RNA prepared from rat cerebral cortex using primers that
span the junction at nt 1735 (Fig. 3C). In addition to the expected 569-bp product (Kalirin-5), a second product 289 bp larger in
size (Kalirin-5.3) was also found (data not shown). The smaller PCR
product was identical in sequence to clones 10/40 and 10/29. The larger
PCR product included a 289-bp insert immediately preceding nt 1735 (Fig. 3C). This 289-bp region included no methionine codons but had two in-frame stop codons. Since the 289-bp region began with a
5' intron donor consensus site (Gggtaagg ... ) and terminated with a 3' intron acceptor consensus site ( ...
ttgctggcagAA), we postulated that the insert represented a
retained intron (17, 18). Consistent with this hypothesis, PCR of rat
genomic DNA with primers spanning the 289-bp region yielded a single
major product of the size expected for inclusion of this region (data not shown).
There are three short open reading frames upstream of the potential
initiator methionine codon at nt 1894; these could reduce initiation of
translation at this site (17). To determine whether Kalirin-5 and 5.3 kb were efficiently translated, we used an in vitro
transcription and translation system and a plasmid that contained only
the first 1.0 kb of Clone 10/29 (Fig. 3D). The first
in-frame methionine codon in this plasmid (pKal-5TnT) is 225 bp from
the 5'-end of the cDNA and corresponds to Met624 (nt
1894) in Kalirin-7a. The nucleotide sequence at this putative start
site is GACAUGU (nt 1891-1897), which is considered an
"adequate" context for initiation of translation based on the
presence of a G at position
3 (17, 18). Methionine residues next
occur at positions 639 and 736. A second plasmid (pKal-5.3TnT)
containing the insert sequence described above was also constructed and
includes 441 bp upstream of nt 1894.
Initiation of translation at Met624 would yield a protein
of 31 kDa. Consistent with this, a protein of approximately 32 kDa was
expressed when either plasmid was used (Fig. 3E). In this system, the plasmid with the retained intron (pKal-5.3TnT) was translated more efficiently than the plasmid lacking the 289-bp insert
(pKal-5TnT). These results suggest that an internal methionine (Met624) in Kalirin-7 can act as an initiation codon when
placed in the context of this shorter mRNA. The protein encoded by
the 5.0- or 5.3-kb Kalirin mRNA (117 kDa) would lack the
Sec14p-like domain and the first four spectrin-like repeats of
Kalirin-7 (Fig. 3F).
Kalirin-9 Encodes a Protein with Two DH-PH Domains--
Western
blot analysis of rat parietal cortex extracts using Kalirin-spectrin
domain antibodies identified several cross-reactive proteins much
larger than Kalirin-7 (190 kDa) or Kalirin-8 (220 kDa) (12). Human Trio
and Caenorhabditis elegans UNC-73A are highly homologous to
Kalirin-7 and -8 but are larger because they include additional
COOH-terminal domains (Fig. 1) (13, 14). Kalirin transcripts of 9, 10, and 12 kb were identified with cDNA probes corresponding to the
spectrin-like repeats, the DH-PH domain, or the COOH terminus of
Kalirin-8 (Fig. 2, lanes 1-4). To determine the
identity of these transcripts, 3'-RACE was performed using a sense
primer located within the SH3 domain of Kalirin-8 (Fig. 4A); our goal was to extend
the Kalirin sequence in the 3' direction without amplifying the
abundant Kalirin-7 and Kalirin-5 cDNAs. After nested PCR, a 2.5-kb
fragment was amplified. This cDNA diverged from Kalirin-8 at nt
5508 (after Met1828), adding another 1.55 kb of open
reading frame and 0.5 kb of 3'-UTR (Fig. 4A). Another clone
was found that did not diverge from Kalirin-8 until nt 5601 (Fig.
4A). When the new 0.5-kb 3'-UTR was used as a Northern blot
probe, a major band at 9 kb as well as minor bands at 3.2 and 7 kb were
observed; therefore, the major form has been called Kalirin-9 (Fig.
4B, lane 2).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
Kalirin-9 encodes an additional DH-PH
domain. A, the open reading frames of Kalirin-8
(K-8) and Kalirin-9 (K-9) are compared. The
nested sense primers used to generate the 2.5-kb RACE product are
indicated. The 3'-RACE product includes DH (dark gray box)
and PH (diagonal striped box) domains. The RACE clone starts
at nt 5143 of Kalirin-8 and diverges after nt 5508. Kalirin-8 includes
215 bp of unique 3'-coding sequence (checkered box). The
inverted black triangle indicates the site at which a 93-bp
fragment can be spliced out of Kalirin-9. B, rat cortex
poly(A)+ RNA (1 µg) was hybridized with either the
DH2-PH2 or the 3'-UTR of Kalirin-9 (K-9 3'-UTR) probe. C,
the domains of Kalirin-9 are drawn to scale; predicted molecular mass,
270 kDa.
|
|
The 270-kDa protein encoded by the Kalirin-9 transcript includes a
second DH domain (DH2) with an adjacent PH domain (PH2) about 1 kb
downstream from the first DH (DH1) and PH (PH1) domains (Fig.
4C). When a DH2-PH2 probe was hybridized to a Northern blot, major bands of 9 and 12 kb were observed as well as well as minor bands
at 3.2, 7, 10, and >15 kb (Fig. 4B, lane 1).
However, only the transcripts at 3.2, 7, and 9 kb hybridized to the
Kal-9 3'-UTR probe (Fig. 4B, lane 2).
Interestingly, a 3.2-kb transcript is also observed in liver,
suggesting that a truncated form of this protein only containing the
DH2-PH2 domain of Kalirin may be expressed in neuronal and non-neuronal tissue.
Kalirin-12 Also Encodes a Putative Protein Kinase
Domain--
Since larger Kalirin transcripts and proteins were
detected, we searched for still longer forms of Kalirin. Kawai et
al. (19) recently identified human Duet, a 1289 amino acid protein
containing adjacent DH and PH domains and a serine/threonine protein
kinase domain (Fig. 5A).
Comparison of Duet to the DH2 and PH2 domains of Kalirin-9 demonstrated
a striking degree of identity. Kalirin-9 (Cys1699 to
Lys2371) is 95% identical at the amino acid level to human
Duet (amino acids 29-701) (Fig. 5A). The protein kinase
domain of Duet also exhibited a high degree of homology to the protein
kinase domain of Trio (58% identity). Therefore, we speculated that
one or more of the largest Kalirin transcripts would encode a form of
Kalirin containing a kinase domain equivalent to the kinase domain of Duet.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 5.
Kalirin-12 encodes a putative Ser/Thr protein
kinase domain. A, the open reading frames of Kalirin-9
(K-9), hDuet, and Kalirin-12 (K-12) are compared. K12s (from
Kalirin-9) and K12as (from hDuet) (arrows)
indicate the location of primers used in RT-PCR to clone a 4.4-kb
fragment that diverged from Kalirin-9 15 bp upstream of the Kalirin-9
stop codon. Kalirin-12 contains the rat homolog of the hDuet Ser/Thr
protein kinase (box with wavy dotted lines). The
first 66 bp of coding sequence in hDuet (open checkered box)
is unique. B, Northern blot analysis of rat cortex
poly(A)+ RNA (1 µg) hybridized with probe specific for
the DH2-PH2 or Kalirin kinase domain. See Fig. 4B for
comparison with Kalirin-9 3'-UTR probe. C, the domains of
Kalirin-12 are drawn to scale; predicted molecular mass, 340 kDa.
|
|
By using a Kalirin sense primer (K12s) upstream of the region of
homology with Duet, and an antisense primer from the 3'-UTR of human
Duet (K12as), a 4.4-kb fragment was amplified (Fig. 5A). When sequenced, this fragment was found to encode the Kalirin SH3, DH2,
and PH2 domains along with a putative serine/threonine protein kinase
domain. After its unique 22-amino acid NH2 terminus, human
Duet is 94% identical to this new form of rat Kalirin. Northern blots
hybridized with a kinase domain probe exhibited a major 12-kb band, as
well as minor bands of 10 kb and >15 kb (Fig. 5B, 2nd lane). A 12-kb message also hybridized to
probes specific for spectrin domains 1-3 and 3-8, DH1-PH1, Kal-8 COOH
terminus, and DH2-PH2. This 340-kDa protein has been designated
Kalirin-12 and contains a Sec14p-like domain, nine spectrin-like
repeats, two DH-PH domains, an SH3 domain, and a putative protein
kinase domain (Fig. 5C). Note that the kinase domain probe
did not recognize a transcript of the size expected for Duet (5.4 kb
(19)) in adult parietal cortex.
PCR Analysis of Alternate Kalirin 5' Sequences--
Three
different Kalirin 5'-ends (a-c) encoding unique
NH2 termini have been identified (Fig.
6A). The a and
b forms are designated based on the original cloning of
P-CIP10a and -10b, respectively. The rat c form corresponds
to human Duo. Each NH2 terminus diverges immediately
upstream of the amino acid sequence GSFR (Fig. 6A), suggesting that there are at least three alternatively spliced Kalirin
5'-ends. We previously used RT-PCR to demonstrate that Kalirin-7
utilized each of these 5'-ends when examined at the level of
transcription (12).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 6.
Kalirin transcripts have multiple
5'-ends. A, Kalirin-a, -b, and
-c denote three different 3'-ends; unique amino acid
sequences are underlined and bold. B,
Kalirin-7, -8, -9, and -12 have distinct 3'-ends. RT-PCR analysis of
rat parietal cortex RNA was carried out using sense primers
Kal-start a, b, and c, and antisense primers
Kal-7/3', Kal-8/3', Kal-9/3', and Kal-12/3'
(arrows) in all possible combinations. C, cortex
total RNA (1 µg) was reverse-transcribed and amplified as described
under "Eperimental Procedures" using the indicated primers. Equal
aliquots of each PCR reaction were electrophoresed on a 0.8% agarose
gel, denatured, and transferred to nitrocellulose for Southern analysis
using a probe to Kalirin spectrin domains 1-3. Reverse transcriptase
was not added to the reaction ( ) to control for any contaminating
DNA.
|
|
To determine which of these 5'-ends were used in the expression of
Kalirin-8, -9, and -12, RT-PCR was performed using sense primers
specific for each 5'-end (Kal-start a, b, c) and antisense primers (Kal-7/3', Kal-8/3', Kal-9/3', and
Kal-12/3') specific for each 3'-end (Fig. 6B). In
the case of Kalirin-12, the antisense primer (Kal-12/3') was
placed upstream of the putative kinase domain to minimize the length of
the product to be amplified. Rat parietal cortex cDNA was amplified
using all primer combinations, and aliquots were electrophoresed on
agarose gels and transferred to membranes for Southern analysis (Fig.
6C).
All three 5'-ends could be detected for Kalirin-7, -9, and -12. In
contrast, although Kalirin-8 transcripts containing the b
and c 5'-ends could be amplified, no Kalirin-8 transcripts
having the a 5'-end were detected. A control PCR using
Kalirin-8a and -8b templates (2.1 × 10
9
pmol of template/reaction or ~1300 molecules of starting template) showed that the Kal-start a + Kal-8/3' primer pair actually
amplified more efficiently than the Kal-start b + Kal-8/3'
primer pair (not shown). Since the Kal-start a primer works
well on control templates, yet the amount of product generated using
this primer in RT-PCR is low, it is likely that relatively few Kalirin
transcripts have the Kal-start a 5'-end.
PCR Analysis of
Kalirin Forms--
Northern blot analysis with
probes specific for Kalirin-9 or Kalirin-12 revealed the presence of
minor mRNAs about 2 kb smaller than the major transcripts
identified by both probes (Fig. 4B, lane 2; Fig.
5B, lane 2). These hybridization patterns were
similar to that observed on blots hybridized with a Kalirin-7-specific probe (Fig. 2, lane 5) in which the smaller Kalirin-5
message had its own unique 5'-end encoding a truncated protein. This
consistent pattern suggested that these minor RNA transcripts (7 kb in
Fig. 4B, lane 2; 10 kb in Fig. 5B,
lane 2) might have the 5'-end identified in Kalirin-5.
To confirm the existence of these transcripts, RT-PCR was again carried
out using antisense primers specific for Kalirin-7, -8, -9. or -12 and
a sense primer specific for the 5'-end of the Kalirin-5 message
(Kal-start
) (Fig.
7A). Products of the expected size were observed by Southern analysis using all four sets of primers
(Fig. 7B), consistent with the suggestion that the minor transcripts described above have the predicted short 5'-end. Southern analysis gave similar results for blots probed with either the Kalirin
DH1-PH1 region or the 289 bp retained intron from the Kalirin-5 5'-UTR.
In an attempt to simplify the naming of the growing number of Kalirin
forms, transcripts having the truncated 5'-end have been designated as
delta (
) forms. Therefore, Kalirin-5 will be called
Kalirin-7,
and the forms shown in Fig. 7A will be called
Kalirin-8,
-9, and -12, respectively.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Multiple forms of Kalirin have a truncated
5'-end. A, sense primer ( ) specific to the 5'-end of
Kalirin-5 was used for RT-PCR in combination with antisense primers
Kal-7/3', Kal-8/3', Kal-9/3', and
Kal-12/3' (arrows). Kalirin-7 is identical to
Kalirin-5 or -5.3 described in Fig. 3. The stippled boxes
indicate the 289-bp retained intron. The checkered boxes
indicate the region of Kalirin (nts 1735-1894) which becomes
5'-noncoding sequence in the truncated message forms. The bent
arrow is located at the putative start site (ATG) at the beginning
of spectrin repeat 5. B, total cortex RNA (1 µg) was
reverse transcribed, amplified and analyzed as described in Fig. 6; the
blot was hybridized with a probe specific for Kalirin DH1-PH1. A
cDNA probe specific for the 289 bp retained intron (stippled
box in A) hybridized with similar intensities as the
DH1-PH1 probe in each case, suggesting that a significant amount of PCR
product observed for each primer pair is derived from cDNAs with
the retained intron.
|
|
Identification of Major Kalirin Proteins in Adult Rat
Brain--
To appreciate the functional significance of the many
Kalirin transcripts identified, we developed form-specific antisera. Anti-peptide sera specific for the COOH termini of Kalirin-7, Kalirin-9, and Kalirin-12 were produced. In addition, we generated an
antiserum specific for the SH3 domain, which should detect Kalirin-9
and Kalirin-12 (and Kalirin-8) but not Kalirin-7 (Fig. 8A). The Kalirin-spectrin
antisera generated previously would detect all forms of Kalirin except
Duet.

View larger version (59K):
[in this window]
[in a new window]
|
Fig. 8.
Identification of major Kalirin proteins
using form-specific antisera. A, the synthetic peptides
and recombinant proteins used to generate form-specific antisera are
indicated. B, Western blot analysis of Kalirin proteins in
extracts of adult rat cortex/hippocampus. Samples were
immunoprecipitated with Kalirin-spectrin antibody ("Experimental
Procedures"). Homogenate (Input, 50 µg) and
immunoprecipitated (IP) proteins (5, 5, 20, 20, and 15% of
the total) were detected by Western blotting with Kalirin-spectrin
antibody (K-spec) or affinity-purified antibodies specific
for individual Kalirin isoforms. Apparent molecular masses of the
various isoforms are indicated. C, Western blot analyses of
Kalirin proteins in extracts of adult rat cortex, olfactory bulb, and
cerebellum (each 40 µg of protein) were performed using the
Kalirin-spectrin antibody. The bands marked Kalirin-7 and -12 were
identified when the blots were stripped and reprobed with form-specific
antisera. The results shown are representative of three or more blots
from each tissue.
|
|
Kalirin proteins were immunoisolated from extracts of rat cortex and
hippocampus using a Kalirin-spectrin antibody. Immune complexes were
then fractionated by SDS-PAGE, and proteins were visualized with
form-specific Kalirin antisera (Fig. 8B). The Kalirin-spectrin antibody detected Kalirin proteins with apparent molecular masses of 115, 190, 370 and 470 kDa; the most prevalent Kalirin protein had a mass of 190 kDa and was previously identified as
Kalirin-7 (12). As expected, the Kalirin forms detected by the
Kalirin-spectrin antibody in the immune complexes were the same forms
detected in the input homogenate. In addition to the 190-kDa Kalirin-7
protein, the antibody specific for the COOH terminus of Kalirin-7
detected a minor protein of 115 kDa, presumably representing the
protein encoded by the
Kalirin-7 transcript (predicted mass 117 kDa). Although
Kalirin-7 transcripts were more prevalent than
Kalirin-7 transcripts, the
Kalirin-7 protein was less prevalent.
The major proteins detected by the antibody specific for the SH3 domain
corresponded to the 370- and 470-kDa proteins detected by the
Kalirin-spectrin antiserum. The antibody to the COOH terminus of
Kalirin-9 detected a major 370-kDa protein, supporting its identification as Kalirin-9. The antibody specific for the COOH terminus of Kalirin-12 detected a major 470-kDa protein band, supporting its identification as Kalirin-12. Since the COOH terminus of
Kalirin-9 contains only 5 unique amino acids and a 19-amino acid
peptide was used to generate the Kalirin-9 antiserum, the minor band at
470 kDa is thought to represent cross-reactivity of the polyclonal
antiserum with sequences common to Kalirin-12. Identification of other
minor bands detected by the various antisera will require further
purification and characterization. Smaller proteins generated by
endoproteolysis of Kalirin-7, -9, or -12 would not be identified by
this screening method since rabbit antisera were used both for
immunoprecipitation and detection.
The nervous system does not show uniform expression of all forms of
Kalirin (Fig. 8C). In the cortex, Kalirin-7 is the major form, and
Kalirin-7 is detectable. By comparison, in the olfactory bulb, Kalirin-7, -9, and -12 are roughly equally represented. For the
same amount of protein loaded onto the gel, there is much less Kalirin
in the cerebellum, and the pattern is yet another mixture of
Kalirin-related proteins.
Differential Localization of Major Kalirin Proteins in Cortical
Neurons--
The Kalirin-7, Kalirin-9, and Kalirin-12 antisera were
used to compare the localization of these major Kalirin proteins in primary cultures of cortical neurons. Kalirin-7 was primarily localized
to punctate structures distributed along neuronal processes (Fig.
9). By contrast, Kalirin-9 was observed
both in neuronal cell bodies and in neuronal processes; the staining
pattern observed with the Kalirin-9 antiserum was more uniform within
the processes than the punctate staining pattern observed with
antiserum to Kalirin-7. Strikingly, Kalirin-12 was largely excluded
from neuronal processes and was found primarily in cell bodies;
occasional bright, vesicular structures were observed, with many
neurons exhibiting a concentration of staining in the perinuclear
region.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 9.
Kalirin isoforms have distinct subcellular
localizations in neurons. Seven- and two-day-old cultures of
dissociated cerebral cortical neurons were immunostained separately
with affinity-purified antibodies specific for Kalirin-7, -9, and -12;
all staining was eliminated when the antibodies were pre-bound to their
antigenic peptides. Scale bar, 50 µm.
|
|
The Multiple Forms of Kalirin--
The Kalirin transcripts
identified appear to arise through the combined use of five different
5'-ends, four different 3'-ends, and alternative splicing of internal
exons (Fig. 10A). The
exon/intron structure of the unc-73 gene has been determined
(14). Comparison of the sequences of rat Kalirin and unc-73
indicates that several of the sites where the Kalirin splice variants
diverge can be aligned with exon/intron junctions in unc-73.
Although almost every combination of 5'-end with 3'-end can be detected
by RT-PCR, the most prevalent 5'-ends are Kal-start b and
c along with Kal-start
with the 289 bp
retained intron; these three 5'-ends are of roughly equal prevalence.
The unique sequences of Kal-start b and c do not
show significant homology to any sequences in the data base.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 10.
Summary diagram of forms and how they relate
to each other. A, the Kalirin core, common to all
Kalirin transcript (except a rat equivalent of human Duet), is shown in
the center of the diagram. Alternative splice sites are indicated by
dashed lines. Translational initiation sites are indicated
by a bent arrow. Known protein domains are indicated.
Translated regions are shown by bold lines, with 5'- and
3'-untranslated regions shown by dotted lines. B,
the major Kalirin proteins, with their catalytic activities and domain
structures, are drawn to scale.
|
|
The
-Kalirin forms, lacking the Sec14p-like domain, are of special
interest. Translation of these transcripts requires initiation at a Met
residue located at the start of the 5th spectrin-like repeat. During
in vitro transcription/translation of Kalirin-7, there was
no indication of internal initiation of translation. The 289-bp
retained intron could be involved in regulating
-Kalirin expression.
Introns near the 5'-ends of mRNAs are often poorly spliced from
mRNA precursors (17, 18).
Expression of the
-Kalirin forms is likely to be of functional
significance. The region of Kalirin preceding the spectrin-like repeats
(rat Kalirin-(15-162)) resembles the COOH-terminal, lipid interacting
part of a Sec14p domain (11). By mediating the binding of Kalirin to
membranes, the Sec14p-like domain could affect its ability to act on
its target Rho family members. This same region of Kalirin (rat
Kalirin-(1-231)) and homologous regions of Dbl and Ost bind the
1 subunit of heterotrimeric G proteins (20). Interestingly,
-Kalirin was identified as an iNOS interactor in a
yeast two-hybrid screen (8); our subsequent studies indicated that iNOS
also interacted with NH2-terminally extended forms of Kalirin.
The genes most closely related to Kalirin also yield multiple
transcripts. UNC-73A and -73B correspond to Kalirin-12 and Kalirin-8; UNC-73B lacks the second DH-PH domain along with the Ig and fibronectin type III domains (14). Only two splice variants of Trio have been
observed; they differ in the region immediately following the second PH
domain (gi 3644048 and gi 3544970). Splicing of Ost (Dbs), a closely
related neuronally expressed Dbl family member, is also complex,
involving multiple NH2- and COOH-terminal regions with
distinct functional domains (21).
 |
DISCUSSION |
With the identification of Kalirin-12, the domain structures of
Kalirin and Trio (13) can be seen to be similar from NH2- to COOH-terminal end (Figs. 1 and 10B). UNC-73A, a C. elegans protein that plays a cell autonomous role in axon
guidance, shares all but the protein kinase domain (14). In the adult
rat, expression of Kalirin is limited to the nervous system (9),
whereas expression of Trio is widespread (13). UNC-73, the only member
of the Trio/Kalirin family identified in C. elegans, is
ubiquitously expressed in the early embryo, with expression growing
more limited in late embryogenesis and after hatching (14).
The Catalytic Domains of Kalirin--
The second DH domains of rat
and human Kalirin (Duet) differ at only 1 of the 198 residues. This
second DH domain of Kalirin is most similar to the second DH domains of
Trio (68% identity) and UNC-73A (49% identity). The homology of the
first and second DH domains of Kalirin (40% identity) is similar to
the homology of Kalirin DH-2 to Dbl (39% identity) or to Ost (38%
identity). Based on sequence homology, the second DH domain of Kalirin
is likely to catalyze GDP/GTP exchange on RhoA (13).
The COOH-terminal kinase domain of Kalirin has the 8 invariant residues
common to protein kinases; unlike most protein kinases, the sequence
predicted for the Mg2+-binding loop (DFG) connecting
-strands 8 and 9 has the sequence DLE (22, 23). The kinase domains
of rat and human Kalirin (Duet) are 99% identical, whereas the kinase
domains of rat Kalirin and human Trio are 58% identical. Duet was
autophosphorylated in an in vitro kinase assay, but no
exogenous substrate has been identified (19). The kinase domain of Trio
has not yet been shown to have catalytic activity (13, 24). If the
kinase domain of Kalirin exhibits substrate specificity as high as that
of another PAM-CD interactor, P-CIP2 (25), identification of the
endogenous substrate may be difficult.
The protein kinases exhibiting the greatest homology to Kalirin kinase
are the death-associated protein kinases (40% identity; GenBankTM accession number X76104) and the myosin light
chain kinases (36% identity; GenBankTM accession number
Q15746). Death-associated protein kinase was identified as a mediator
of apoptosis induced by
-interferon (26); it is interesting to note
that expression of a fragment of Kalirin reversed the inhibitory effect
of
-interferon/lipopolysaccharide treatment on secretion from
corticotrope tumor cells (8). Conventional myosin light chain kinase is
a Ca2+/calmodulin-dependent protein kinase that
binds tightly to actomyosin-containing filaments (27).
Non-catalytic Domains in Kalirin--
Several of the domains
identified in Kalirin may allow it to interact with lipids or other
proteins. The second PH domains of rat and human Kalirin are 95%
identical. Kalirin PH-2 is 51% identical to Trio PH-2 and 29-33%
identical to the first PH domains of Kalirin and Trio, the PH domain of
Ost and the two PH domains of UNC-73A. PH domains have been implicated
in binding to phosphoinositides, to the 
subunits of
heterotrimeric G proteins, and to cytoskeletal components and are
essential to the normal function of Dbl family members (1, 28, 29). The
first PH domain of Trio targets the protein to the cytoskeleton
(30).
When the region between the first and second DH-PH domains of Kalirin
was analyzed, two interesting homologies were revealed. First the
SH3-like domain is homologous to the third SH3 domain in Dock, a
Drosophila SH2/SH3 adapter protein involved in photoreceptor cell axon guidance and targeting (32% identity; GenBankTM
accession number U57816) (31). This region is immediately followed by a
194-amino acid region exhibiting 23% identity to ABP1
(GenBankTM accession number X59720), a yeast actin-binding
protein (Fig. 10B).
The region between the second DH-PH domain and the Ig-like domain that
precedes Kalirin-kinase has a Pro-rich region that shares homology with
a region of N-WASP (43% identity over a 44-amino acid region with 10 of 13 Pro residues conserved). In N-WASP, a protein that regulates
actin polymerization, this proline-rich region binds to profilin and
Ash/Grb2 (32).
An Ig-like region precedes the Kalirin-kinase domain; this 214-amino
acid region, comprising two Ig repeats, is 96% identical in rat and
human Kalirin. Human Trio contains one Ig repeat that is 55% identical
to Kalirin. Other intracellular molecules containing Ig repeats include
giant kinases like titin (GenBankTM accession number I38344) and
twitchin (GenBank accession number Z73897); several of the Ig repeats
in titin exhibit 30% identity to this region of Kalirin. These
independently folded globular domains are generally protease-resistant
and facilitate specific protein-protein interactions (33, 34). In both
titin and myosin light chain kinase, the region homologous to Kalirin
includes the kinase domain and the preceding Ig domain. The Ig motif at
the NH2 terminus of myosin light chain kinase is involved
in its binding to filaments (27). Interestingly, Duet, which includes
the entire Ig domain, localized to actin-associated cytoskeletal
elements following transient expression in NIH-3T3 cells (19).
The Major Kalirin Proteins--
In order to relate the Kalirin
proteins detected on Western blots to the major Kalirin transcripts, we
used immunoprecipitation with an antibody to the spectrin-like repeats
followed by Western blot analysis with more selective antisera. The
data presented are all from adult rat cortex; our preliminary data
indicate that dramatic changes in Kalirin expression occur during early
postnatal development. Many factors make it difficult to relate
mRNA prevalence to protein levels, but Kalirin-7 is identified as a
major form by both methods. Although the
-Kalirin-7 mRNA is
prevalent, the corresponding 115-kDa protein is barely detectable;
diminished translational efficiency or rapid protein turnover could
contribute to the pattern observed. At present we do not have reagents
to distinguish Kalirin proteins with the a, b, or
c sequences at their NH2 terminus. Based on both
Northern and Western blot analysis, levels of Kalirin-9 and Kalirin-12
expression are similar. Although these Kalirin proteins are not
expressed at levels as high as Kalirin-7, the fact that they are
localized differently in cultured neurons suggests that they subserve
specific functions.
At least in adult rat cortex, we see no evidence for expression of a
protein equivalent to human Duet (19). Northern blots hybridized with
probes that would identify a Duet-like transcript lack a band in the
appropriate size range. A Duet-like protein would have a mass of about
144 kDa and be visualized by the Kalirin-kinase antiserum. No protein
of this mass was observed. Our initial studies indicate that Kalirin is
expressed in many non-neuronal sites during embryogenesis, and a
Duet-like protein may be identified. Alternatively, expression of a
Duet-like protein may reflect species-specific splicing of this complex
gene. Comparison of rat, mouse, and human genomic DNA indicates that
the 289-bp retained intron in
-Kalirin is unique to rat (data not shown).
The Biology of Dual Function GEFs--
In considering the
functions of Kalirin, it is useful to estimate its size in comparison
to the components with which it might interact. Crystal structures have
been determined for many of the domains found in Kalirin. The partial
Sec14p-like domain should span approximately 3 nm (35). The three-helix
bundle of each spectrin-like repeat would be approximately 5 nm long
(36). The first DH-PH domain of Trio is 7 nm long (37). An SH3 motif is
another 3 nm. The two Ig repeats could span about 8 nm (33). The
protein kinase domain should form an ellipsoid about 8 nm in length
(38). Stretched out in a linear form, the length spanned by one Kalirin
molecule could reach 85 nm or more. The vesicles used for trafficking
are 40-200 nm in diameter, and a single actin filament is about 7 nm
in diameter. Thus, Kalirin is large enough that one of its functions
may be tethering together components whose functions must be
coordinately regulated, much as spectrin and ankyrin skeletons function
in networks near organelles (39-41).
Although the Dbl family is large, Kalirin, Trio and unc-73
are the only members with multiple Dbl domains. As such, they can be
expected to coordinate the actions of the different Rho family members
with which their two catalytic domains interact. Trio, identified by
its interaction with LAR, a receptor-like protein tyrosine phosphatase,
is thought to coordinate spatial and temporal changes in the actin
cytoskeleton with cell-matrix interactions that are important in cell
growth and migration (42). C. elegans with the most severe
unc-73 mutations are nearly paralyzed and have withered
tails, ectopic subventral vulvae, and defects in egg laying (14).
Overexpression of Kalirin-8 in corticotrope tumor cells results in
altered metabolism of PAM and marked extension of branched neuritic
processes (9), and Kalirin-7 is highly localized to the post-synaptic
density fraction in adult rat brain. The activity of Dbl-family members
can be affected by phosphorylation, binding to membranes, and by the
non-catalytic NH2-terminal domain (1). A key to
understanding the functions of Kalirin will be identification of inputs
regulating its localization and its many potential activities. The
distinctly different localization of Kalirin-7, Kalirin-9, and
Kalirin-12 in cortical neurons suggests different roles for each
protein. Kalirin, through its several catalytic domains and multiple
protein and lipid interacting regions, may coordinate changes in the
actin cytoskeleton and the secretory machinery with peptide processing
events in the lumen of the secretory pathway (43).
 |
ACKNOWLEDGEMENTS |
We thank Henry Keutmann (Massachusetts
General Hospital) for synthesis of the peptides used to generate
antisera; Kate Deanehan for affinity purification of antisera; and
Marie Bell and Lixian Jin for general laboratory assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grant DK-32948.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Current address and to whom correspondence should be
addressed: Dept. of Neuroscience, University of Connecticut Health
Center, MC3401, 263 Farmington Ave., Farmington, CT 06030-3401. Tel.: 860-679-8894; Fax: 860-679-8766; E-mail: mains@nso.uchc.edu.
Published, JBC Papers in Press, April 20, 2000, DOI 10.1074/jbc.M000676200
 |
ABBREVIATIONS |
The abbreviations used are:
GEFs, GDP/GTP
exchange factors;
DH, Dbl (deleted in B-cell lymphoma) homology;
PAM, peptidylglycine
-amidating monooxygenase;
pBS, pBluescript;
P-CIP, PAM-COOH-terminal interactor protein;
PH, pleckstrin homology;
RACE, rapid amplification of cDNA ends;
RT-PCR, reverse
transcription-polymerase chain reaction;
PAGE, polyacrylamide gel
electrophoresis;
SH3, src homology 3;
iNOS, inducible nitric-oxide
synthase;
nt, nucleotides;
kb, kilobase pair;
bp, base pair;
UTR, untranslated region;
RACE, rapid amplification of cDNA ends.
 |
REFERENCES |
| 1.
|
Cerione, R. A.,
and Zheng, Y.
(1996)
Curr. Opin Cell Biol.
8,
216-222
|
| 2.
|
Whitehead, I. P.,
Campbell, S.,
Rossman, K. L.,
and Der, C. J.
(1997)
Biochim. Biophys. Acta
1332,
F1-F23
|
| 3.
|
Kjoller, L.,
and Hall, A.
(1999)
Exp. Cell Res.
253,
166-179
|
| 4.
|
Zohn, I. M.,
Campbell, S. L.,
Khosravi-Far, R.,
Rossman, K. L.,
and Der, C. J.
(1998)
Oncogene
17,
1415-1438
|
| 5.
|
Kins, S.,
Betz, H.,
and Kirsch, J.
(2000)
Nat. Neurosci.
3,
22-29
|
| 6.
|
Alam, M. R.,
Caldwell, B. D.,
Johnson, R. C.,
Darlington, D. N.,
Mains, R. E.,
and Eipper, B. A.
(1996)
J. Biol. Chem.
271,
28636-28640
|
| 7.
|
Colomer, V.,
Engelender, S.,
Sharp, A. H.,
Duan, K.,
Cooper, J. K.,
Lanahan, A.,
Lyford, G.,
Worley, P.,
and Ross, C. A.
(1997)
Hum. Mol. Genet.
6,
1519-1525
|
| 8.
|
Ratovitski, E. A.,
Alam, M. R.,
Quick, R. A.,
McMillan, A.,
Bao, C.,
Hand, T. A.,
Johnson, R. C.,
Mains, R. E.,
Eipper, B. A.,
and Lowenstein, C. J.
(1999)
J. Biol. Chem.
274,
993-999
|
| 9.
|
Alam, M. R.,
Johnson, R. C.,
Darlington, D. N.,
Hand, T. A.,
Mains, R. E.,
and Eipper, B. A.
(1997)
J. Biol. Chem.
272,
12667-12675
|
| 10.
|
Mains, R. E.,
Alam, M. R.,
Johnson, R. C.,
Darlington, D. N.,
Back, N.,
Hand, T. A.,
and Eipper, B. A.
(1999)
J. Biol. Chem.
274,
2929-2937
|
| 11.
|
Aravind, L.,
Neuwald, A. F.,
and Ponting, C. P.
(1999)
Current Biology
9,
R195-R197
|
| 12.
|
Penzes, P.,
Johnson, R. C.,
Alam, M. R.,
Kambampati, V.,
Mains, R. E.,
and Eipper, B. A.
(2000)
J. Biol. Chem.
275,
6395-6403
|
| 13.
|
Debant, A.,
Serra-Pages, C.,
Seipel, K.,
O'Brien, S.,
Tang, M.,
Park, S. H.,
and Streuli, M.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5466-5471
|
| 14.
|
Steven, R.,
Kubiseski, T. J.,
Zheng, H.,
Kulkarni, S.,
Mancillas, J.,
Morales, A. R.,
Hogue, C. W. V.,
Pawson, T.,
and Culotti, J. G.
(1998)
Cell
92,
785-795
|
| 15.
|
Bloomquist, B. T.,
Eipper, B. A.,
and Mains, R. E.
(1991)
Mol. Endocrinol.
5,
2014-2024
|
| 16.
|
Johnson, R. C.,
Darlington, D. N.,
Hand, T. A.,
Bloomquist, B. T.,
and Mains, R. E.
(1994)
Endocrinology
135,
1178-1185
|
| 17.
|
Kozak, M.
(1996)
Mamm. Genome
7,
563-574
|
| 18.
|
Kozak, M.
(1999)
Gene (Amst.)
234,
187-208
|
| 19.
|
Kawai, T.,
Sanjo, H.,
and Akira, S.
(1999)
Gene (Amst.)
227,
249-255
|
| 20.
|
Nishida, K.,
Kaziro, Y.,
and Satoh, T.
(1999)
FEBS Lett.
459,
186-190
|
| 21.
|
Lorenzi, M. V.,
Castagnino, P.,
Chen, Q.,
Hori, Y.,
and Miki, T.
(1999)
Oncogene
18,
4742-4755
|
| 22.
|
Hanks, S. K.,
and Quinn, A. M.
(1998)
in
Protein Phosphorylation
(Sefton, B. M.
, and Hunter, T., eds), Vol. 2
, pp. 39-63, Academic Press, Boston
|
| 23.
|
Taylor, S. S.,
and Radzio-Andzelm, E.
(1994)
in
Cyclic AMP-dependent Protein Kinase
(Woodgett, J. R., ed)
, pp. 1-29, IRL Press at Oxford University Press, Oxford
|
| 24.
|
Bellanger, J. M.,
Lazaro, J. B.,
Diriong, S.,
Fernandez, A.,
Lamb, N.,
and Debant, A.
(1998)
Oncogene
16,
147-152
|
| 25.
|
Caldwell, B. D.,
Darlington, D. N.,
Penzes, P.,
Johnson, R. C.,
Eipper, B. A.,
and Mains, R. E.
(1999)
J. Biol. Chem.
274,
34646-34656
|
| 26.
|
Deiss, L. P.,
Feinstein, E.,
Berissi, H.,
Cohen, O.,
and Kimchi, A.
(1994)
Genes Dev.
9,
15-30
|
| 27.
|
Stull, J. T.,
Lin, P. J.,
Krueger, J. K.,
Trewhella, J.,
and Zhi, G.
(1998)
Acta Physiol. Scand.
164,
471-482
|
| 28.
|
Wang, D. S.,
Deng, T.,
and Shaw, G.
(1997)
Biochem. Biophys. Res. Commun.
234,
183-189
|
| 29.
|
Michiels, F.,
Stam, J. C.,
Hordijk, P. L.,
van der Kammen, R. A.,
Ruuls-Van Stalle, L.,
Feltkamp, C. A.,
and Collard, J. G.
(1997)
J. Cell Biol.
137,
387-398
|
| 30.
|
Bellanger, J. M.,
Zugasti, O.,
Lazaro, J. B.,
Diriong, S.,
Lamb, N.,
Sardet, C.,
and Debant, A.
(1998)
C. R. Soc. Biol.
192,
367-374
|
| 31.
|
Garrity, P. A.,
Rao, Y.,
Salecker, I.,
McGlade, J.,
Pawson, T.,
and Zipursky, S. L.
(1996)
Cell
85,
639-650
|
| 32.
|
Suetsugu, S.,
Miki, H.,
and Takenawa, T.
(1998)
EMBO J.
17,
6516-6526
|
| 33.
|
Kenny, P. A.,
Liston, E. M.,
and Higgins, D. G.
(1999)
Gene (Amst.)
232,
11-23
|
| 34.
|
Gregorio, C. C.,
Granzier, H.,
Sorimachi, H.,
and Labeit, S.
(1999)
Curr. Opin. Cell Biol.
11,
18-25
|
| 35.
|
Sha, B.,
Phillips, S. E.,
Bankaitis, V. A.,
and Luo, M.
(1998)
Nature
391,
506-510
|
| 36.
|
Yan, Y.,
Winograd, E.,
Viel, A.,
Cronin, T.,
Harrison, S. C.,
and Branton, D.
(1993)
Science
262,
2027-2030
|
| 37.
|
Liu, X.,
Wang, H.,
Eberstadt, M.,
Schnuchel, A.,
Olejniczak, E. T.,
Meadows, R. P.,
Schkeryantz, J. M.,
Janowick, D. A.,
Harlan, J. E.,
Harris, E. A.,
Staunton, D. E.,
and Fesik, S. W.
(1998)
Cell
95,
269-277
|
| 38.
|
Zheng, J.,
Knighton, D. R.,
Xuong, N. H.,
Parello, J.,
Taylor, S. S.,
and Sowadski, J. M.
(1992)
Acta Crystallogr. Sect. B Struct. Sci.
48,
241-244
|
| 39.
|
DeMatteis, M. A.,
and Morrow, J. S.
(1998)
Curr. Opin. Cell Biol.
10,
542-529
|
| 40.
|
Holleran, E. A.,
and Holzbaur, E. L.
(1998)
Trends Cell Biol.
8,
26-29
|
| 41.
|
Stankewich, M. C.,
Tse, W. T.,
Peters, L. L.,
Ch'ng, Y.,
John, K. M.,
Stabach, P. R.,
Devarajan, P.,
Morrow, J. S.,
and Lux, S. E.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
14158-14163
|
| 42.
|
Seipel, K.,
Medley, Q. G.,
Kedersha, N. L.,
Zhang, X. A.,
O'Brien, S. P.,
Serra-Pages, C.,
Hemler, M. E.,
and Streuli, M.
(2000)
J. Cell Sci.
112,
1825-1834
|
| 43.
|
Zhou, A.,
Webb, G.,
Zhu, X.,
and Steiner, D. F.
(1999)
J. Biol. Chem.
274,
20745-20748
|
| 44.
|
Graziani, G.,
Ron, D.,
Eva, A.,
and Srivastava, S. K.
(1989)
Oncogene
4,
823-829
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike